Register for our free email digests:
Becton, Dickinson and Company
https://www.bd.com/en-us
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Becton, Dickinson and Company
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
GSK Ends Tough Week With Ulcerative Colitis Therapy Termination
If bad luck comes in threes, GSK will be delighted to see the end of this week with dostarlimab approval delayed, bintrafusp failing in lung cancer and a Phase II of an ulcerative colitis drug discontinued.
Dr Reddy’s Wants To Break Into Top Five In India
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
Beam And Verve Benefit From Buzz Around Base-Editing Therapies
Companies claim their technologies provide more precise editing as they raise funds, but CRISPR companies remain in the lead.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Diagnostic Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- BD
- BD Medical
- Bridger Biomed, Inc.
- Caesarea Medical Electronics
- CareFusion
- Carmel Pharma, Inc.
- Carmel Pharma, AB
- Cellular Research, Inc.
- C.R. Bard, Inc.
- CRISI Medical Systems
- Davol, Inc.
- Embo Medical Limited
- FlowCardia, Inc.
- GenCell Biosystems, Ltd.
- GeneOhm Sciences
- Liberator Medical, Inc.
- Lutonix, Inc.
- Medafor, Inc.
- Medicon, Inc.
- Neomend, Inc.
- Sirigen Group Limited
- TriPath Imaging
- TVA Medical, Inc.
- Rochester Medical, Inc.
- Safety Syringes Inc.
- Vascular Pathways, Inc.